43 related articles for article (PubMed ID: 21287620)
1. Prediction of protein binding regions.
Chennamsetty N; Voynov V; Kayser V; Helk B; Trout BL
Proteins; 2011 Mar; 79(3):888-97. PubMed ID: 21287620
[TBL] [Abstract][Full Text] [Related]
2. Prediction of aggregation prone regions of therapeutic proteins.
Chennamsetty N; Voynov V; Kayser V; Helk B; Trout BL
J Phys Chem B; 2010 May; 114(19):6614-24. PubMed ID: 20411962
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
Holbrook MR; Slakey LL; Gross DJ
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
[TBL] [Abstract][Full Text] [Related]
4. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
5. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
6. Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.
Mustafa M; Mirza A; Kannan N
Proteins; 2011 Jan; 79(1):99-114. PubMed ID: 20938978
[TBL] [Abstract][Full Text] [Related]
7. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
8. Aggregation-prone motifs in human immunoglobulin G.
Chennamsetty N; Helk B; Voynov V; Kayser V; Trout BL
J Mol Biol; 2009 Aug; 391(2):404-13. PubMed ID: 19527731
[TBL] [Abstract][Full Text] [Related]
9. Design and application of antibody cysteine variants.
Voynov V; Chennamsetty N; Kayser V; Wallny HJ; Helk B; Trout BL
Bioconjug Chem; 2010 Feb; 21(2):385-92. PubMed ID: 20092294
[TBL] [Abstract][Full Text] [Related]
10. A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity.
Blinov ML; Faeder JR; Goldstein B; Hlavacek WS
Biosystems; 2006; 83(2-3):136-51. PubMed ID: 16233948
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.
Aifa S; Frikha F; Miled N; Johansen K; Lundström I; Svensson SP
Biochem Biophys Res Commun; 2006 Aug; 347(2):381-7. PubMed ID: 16793002
[TBL] [Abstract][Full Text] [Related]
12. Affinity regulates spatial range of EGF receptor autocrine ligand binding.
DeWitt A; Iida T; Lam HY; Hill V; Wiley HS; Lauffenburger DA
Dev Biol; 2002 Oct; 250(2):305-16. PubMed ID: 12376105
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
14. The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s).
Poppleton HM; Sun H; Mullenix JB; Wiepz GJ; Bertics PJ; Patel TB
Arch Biochem Biophys; 2000 Nov; 383(2):309-17. PubMed ID: 11185568
[TBL] [Abstract][Full Text] [Related]
15. Activation of epidermal growth factor receptor by epidermal growth factor.
Sherrill JM; Kyte J
Biochemistry; 1996 May; 35(18):5705-18. PubMed ID: 8639530
[TBL] [Abstract][Full Text] [Related]
16. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
17. Theoretical investigations of prostatic acid phosphatase.
Sharma S; Pirilä P; Kaija H; Porvari K; Vihko P; Juffer AH
Proteins; 2005 Feb; 58(2):295-308. PubMed ID: 15578709
[TBL] [Abstract][Full Text] [Related]
18. Creation and biophysical characterization of a high-affinity, monomeric EGF receptor ectodomain using fluorescent proteins.
Kozer N; Henderson C; Bailey MF; Rothacker J; Nice EC; Burgess AW; Clayton AH
Biochemistry; 2010 Sep; 49(35):7459-66. PubMed ID: 20715761
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo simulations of the peptide recognition at the consensus binding site of the constant fragment of human immunoglobulin G: the energy landscape analysis of a hot spot at the intermolecular interface.
Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Freer ST; Rose PW
Proteins; 2002 Aug; 48(3):539-57. PubMed ID: 12112677
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.
Jorissen RN; Epa VC; Treutlein HR; Garrett TP; Ward CW; Burgess AW
Protein Sci; 2000 Feb; 9(2):310-24. PubMed ID: 10716183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
